Cisplatin and Nano-particle Formulations of Cisplatin for Cancer Therapy: A Review
Popsy Raj, Bharat Lal, Manoj Gadewar, Anita Singh & G. K. Prashanth · Journal of Pharmaceutical Research International · 2022
Cisplatin (cis-(diammine)dichloridoplatinum(II)) is the first platinum-based compound approved by the United States Food and Drug Administration (FDA) (U.S.). This is a first-line chemotherapeutic treatment used alone or combined with other anticancer drugs to treat a broad spect...
Open access
Research Article
10.9734/jpri/2022/v34i14A35636